Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News

Hearing Checks Boost Detection of Cytomegalovirus in Infants

The findings underscore why many experts are still pushing for universal screening.

First MS Mobility Drug Gets Green Light From NHS England

NHS England reverses a 2022 NICE rejection now fampridine is off patent, bringing England into line with the rest of the UK.

Why Oropouche Virus Is Gaining Global Attention

Researchers report rapid spread, widespread underdiagnosis, and growing travel-associated infections, raising concerns about future outbreaks beyond Latin America.

Pharmacies Left Out as Pubs Get Rates Cut

Pharmacy associations criticise the government's decision to offer another business rates cut to pubs and live music venues while excluding high street pharmacies again.

A Blood Test for Colon Cancer Screening? Not So Fast!

Dr Aasma Shaukat says that the convenience of a blood test for colorectal cancer should not outweigh the performance of a blood test, especially when weighed against the other options available.

To Treat or Not to Treat? The COVID Conundrum

A 31-year-old presents with COVID and wants medication to fight the infection. Dr Chuck Vega weighs in on the evidence for standard-risk patients.

Todays Updates

Glioma Outcomes Shaped by Subtype More Than Tx Sequence

In high-risk low-grade glioma, starting with temozolomide or radiotherapy yields similar survival.

Stem Cell Transplant Associated With Better PFS in NKTCL

Researchers aim to evaluate the effectiveness of ASCT as consolidation therapy for patients with advanced-stage natural killer/T-cell lymphoma who have attained their first complete remission.

Todays Updates

Glioma Outcomes Shaped by Subtype More Than Tx Sequence

In high-risk low-grade glioma, starting with temozolomide or radiotherapy yields similar survival.

Stem Cell Transplant Associated With Better PFS in NKTCL

Researchers aim to evaluate the effectiveness of ASCT as consolidation therapy for patients with advanced-stage natural killer/T-cell lymphoma who have attained their first complete remission.

Latest News

The findings underscore why many experts are still pushing for universal screening.

NHS England reverses a 2022 NICE rejection now fampridine is off patent, bringing England into line with the rest of the UK.

Researchers report rapid spread, widespread underdiagnosis, and growing travel-associated infections, raising concerns about future outbreaks beyond Latin America.

Pharmacy associations criticise the government's decision to offer another business rates cut to pubs and live music venues while excluding high street pharmacies again.

Dr Aasma Shaukat says that the convenience of a blood test for colorectal cancer should not outweigh the performance of a blood test, especially when weighed against the other options available.

A 31-year-old presents with COVID and wants medication to fight the infection. Dr Chuck Vega weighs in on the evidence for standard-risk patients.

News All Time

At-Home Lecanemab: ‘Encouraging’ First Data

Early real-world data suggest that weekly at-home subcutaneous lecanemab may offer a feasible alternative to ongoing IV maintenance treatment for early Alzheimer’s disease.

Adult-Gerontology Nursing the Future of Elder Care

Adult-gerontology nurse practitioners might be the future of elder care as opportunities grow.

CSF Biomarker Panel May Improve Diagnosis of CNS Lymphoma

A prospective multicenter study validates three cerebrospinal fluid biomarkers that may aid diagnosis of suspected primary CNS lymphoma.

Health Data Platform Connects Hospitals Across Provinces

The VITAL system collects near real-time hospital data with the aim of optimizing healthcare delivery, research, and innovation while protecting privacy.

Focal Therapy Shows Favorable Long-Term Outcomes

A large registry study finds low 10-year prostate cancer mortality after focal HIFU or cryotherapy, but experts caution randomized comparisons with standard treatments are needed.

Blood Test Flags Gynaecologic Cancer Risk in NHS Trial

A blood test correctly flags 99% of gynaecologic cancers as high risk in the largest NHS AI triage trial yet.

Parental Anxiety Persists Up to 2 Years After NICU Discharge

Parents of extremely premature infants show higher anxiety levels well beyond hospital discharge.

Holmium Enucleation Safe for Recurrent Prostatic Obstruction

Holmium laser enucleation of the prostate appears safe and effective for patients who have recurrent benign prostatic obstruction.

Noncardia Gastric Cancer Risk Higher in Some Ethnic Groups

Hispanic and Asian populations in the US show a clinically meaningful risk for noncardia gastric cancer up to two decades earlier than non-Hispanic White populations.

High Suspicion for Cyclosporiasis Needed, Tracing Continues

With the outlines shifting in the current outbreak, testing for the parasite is a no-brainer, say experts.

Fecal Biomarkers Distinguish Pediatric IBD From Diarrhea

Fecal eosinophil-derived neurotoxin, lipocalin-2, and calprotectin are elevated in pediatric IBD, with calprotectin best distinguishing IBD from acute diarrhea, a recent study shows.

First Evidence That Targeting Tau May Slow Cognitive Decline

The investigational drug diranersen led to tau reduction with the lowest dose showing the most consistently positive clinical effect.

Health Disparities and Access Barriers in GAD Care

Matthew Macaluso, DO, comments on systemic barriers that delay GAD diagnosis, highlighting the need for better access to psychiatric care and integrated treatment pathways.

Lecanemab for AD Shows Sustained Benefit in Real-World Study

Real-world data suggest lecanemab’s safety and efficacy mirror results from the pivotal Clarity AD trial and highlight the growing use of blood-based biomarkers in clinical practice.

Chemo Tied to Longer Survival After Pelvic Exenteration

A retrospective international study suggests adjuvant chemotherapy is associated with longer survival after pelvic exenteration in patients with high-risk gynecologic cancers.

When the Algorithm Knows the Risk but Misses the Fear

AI may flag low clinical risk, but it can still miss the patient’s fear, story, and lived experience.

Recommended News For You

Belzutifan Plus Pembro Approved for Adjuvant RCC

Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC

Results for Prostate Cancer Are Associated With PSA Nadir 6 Months After Primary RT.

SCOTUS Grapples With Multibillion-Dollar Lawsuits Over Roundup Cancer Claims

New drug combination shows particularly good results in patients with HPV-negative head and neck cancer

Atezolizumab + Cabozantinib Postpones mCRPC Progression.

When it comes to obesity-related cancers, where you shop for food matters

Recommended Articles For You

Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression 

Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know 

The Impact of Microadenoma on Hormonal Health 

Unlocking the Potential of Red Bone Marrow in the Formation of Blood Cells 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study sheds light on challenges for women of color after breast cancer surgery

2.

FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials

3.

Making informed decisions and managing regret after prostate cancer treatment

4.

What Comes After Cancer?

5.

Q&A: When will individuals be able to receive customized cancer vaccines?

1.

Future-Ready Cancer Screening: What Every Clinician Should Know in 2025

2.

Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine

3.

Exploring The Causes and Consequences of Low Transferrin Saturation

4.

Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy

5.

Erythropoietic Activity Biomarkers in Functional Hematology

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part I

2.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

3.

Thromboprophylaxis In Medical Settings

4.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

5.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot